Abstract

IntroductionInternational investment in the response to HIV and AIDS has plateaued and its future level is uncertain. With many countries committed to ending the epidemic, it is essential to allocate available resources efficiently over different response periods to maximize impact. The objective of this study is to propose a technique to determine the optimal allocation of funds over time across a set of HIV programmes to achieve desirable health outcomes.MethodsWe developed a technique to determine the optimal time-varying allocation of funds (1) when the future annual HIV budget is pre-defined and (2) when the total budget over a period is pre-defined, but the year-on-year budget is to be optimally determined. We use this methodology with Optima, an HIV transmission model that uses non-linear relationships between programme spending and associated programmatic outcomes to quantify the expected epidemiological impact of spending. We apply these methods to data collected from Zambia to determine the optimal distribution of resources to fund the right programmes, for the right people, at the right time.Results and discussionConsidering realistic implementation and ethical constraints, we estimate that the optimal time-varying redistribution of the 2014 Zambian HIV budget between 2015 and 2025 will lead to a 7.6% (7.3% to 7.8%) decrease in cumulative new HIV infections compared with a baseline scenario where programme allocations remain at 2014 levels. This compares to a 5.1% (4.6% to 5.6%) reduction in new infections using an optimal allocation with constant programme spending that recommends unrealistic programmatic changes. Contrasting priorities for programme funding arise when assessing outcomes for a five-year funding period over 5-, 10- and 20-year time horizons.ConclusionsCountries increasingly face the need to do more with the resources available. The methodology presented here can aid decision-makers in planning as to when to expand or contract programmes and to which coverage levels to maximize impact.

Highlights

  • International investment in the response to HIV and AIDS has plateaued and its future level is uncertain

  • The aim of this study is to advance allocative efficiency methodologies by presenting an approach to calculate the optimal allocation of resources over time across HIV programmes

  • voluntary medical male circumcision (VMMC) and antiretroviral therapy (ART) programmes are prioritized in this allocation, with funding to prevention of motherto-child transmission (PMTCT) and HIV testing and counselling (HTC) remaining at roughly current levels

Read more

Summary

Introduction

International investment in the response to HIV and AIDS has plateaued and its future level is uncertain. Methods: We developed a technique to determine the optimal time-varying allocation of funds (1) when the future annual HIV budget is pre-defined and (2) when the total budget over a period is pre-defined, but the year-on-year budget is to be optimally determined We use this methodology with Optima, an HIV transmission model that uses non-linear relationships between programme spending and associated programmatic outcomes to quantify the expected epidemiological impact of spending. Allocative efficiency can be quantitatively analyzed via mathematical and economic modelling, using data on epidemiology, programme expenditure and intervention effectiveness (under setting-specific political and implementation constraints) Such analyses can estimate the combination of programmes likely to have greatest impact against defined health objectives and in turn inform resource allocation planning [6,7]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call